Accès gratuit
Numéro
Ann. Fr. Med. Urgence
Volume 5, Numéro 1, Janvier 2015
Page(s) 9 - 15
Section Article Original / Original Article
DOI https://doi.org/10.1007/s13341-015-0502-7
Publié en ligne 14 janvier 2015
  • Michel P, Lathelize M, Domecq S, et al (2011) Les événements indésirables graves dans les établissements de santé: fréquence, évitabilité et acceptabilité, Études et résultats. DREES p. 761. [Google Scholar]
  • Imbs JL, Pouyanne P, Haramburu F, et al (1999) Iatrogenic medication: estimation of its prevalence in French public hospitals. Therapy 54:21–27. [Google Scholar]
  • Pouyanne P, Haramburu F, Imbs JL, et al (2000) Hospitalisations due to adverse drug reactions: a cross sectional study in medical departments. BMJ 320:1036. [CrossRef] [PubMed] [Google Scholar]
  • Centres régionaux de pharmacovigilance (2007) Etude EMIR: Effets indésirables des médicaments: Incidence et risque, sur les hospitalisations liées à un effet indésirable médicamenteux. http://www.sante.gouv.fr/IMG/pdf/EMIR.pdf. Dernier accès le 7 septembre 2014 [Google Scholar]
  • Palareti G, Leali N, Coccheri S, et al (1996) Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet 348:423–428. [CrossRef] [PubMed] [Google Scholar]
  • Sjöblom L, Hardemark HG, Lindgren A, et al (2001. Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke 32:2567–2574. [CrossRef] [PubMed] [Google Scholar]
  • Go AS, Hylek EM, Chang Y, et al (2003) Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 290:2685–2692. [CrossRef] [PubMed] [Google Scholar]
  • Flaherty ML, Kissela B, Woo D, et al (2007) The increasing incidence of anticoagulant associated intracerebral hemorrhage. Neurology 68:116–121. [CrossRef] [PubMed] [Google Scholar]
  • Hart RG, Tonarelli SB, Pearce LA (2005) Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke 36:1588–1593. [CrossRef] [PubMed] [Google Scholar]
  • Bershad EM, Suarez JI (2010) Prothrombin complex concentrates for oral anticoagulant therapy-related intracranial hemorrhage: a review of the literature. Neurocrit Care 12:403–413. [CrossRef] [PubMed] [Google Scholar]
  • Hylek EM, Singer DE (1994) Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 120:897–902. [CrossRef] [PubMed] [Google Scholar]
  • Hart RG, Pearce LA, Aguilar MI (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146:857–867. [CrossRef] [PubMed] [Google Scholar]
  • Freeman WD, Aguilar MI (2008) Management of warfarinrelated intracerebral hemorrhage. Expert Rev Neurother 8:271–290. [CrossRef] [PubMed] [Google Scholar]
  • Rosand J, Eckman MH, Knudsen KA, et al (2004) The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 164:880–884. [CrossRef] [PubMed] [Google Scholar]
  • Pernod G, Godiér A, Gozalo C, et al (2010) French National Authority for Health. French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding). Thromb Res 126:167–174. [CrossRef] [PubMed] [Google Scholar]
  • Beyth RJ, Quinn LM, Landefeld CS (1998) Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 105:91–99. [CrossRef] [PubMed] [Google Scholar]
  • Moustafa F, Arnaud A, Dublanchet N, et al (2014) Évaluation de la réversion par concentrés de complexes prothrombiniques et vitamine K des patients porteurs de prothèse valvulaire mécanique admis dans un service d’urgence suite à un accident hémorragique grave. Ann Fr Med Urg 4:82–88. [CrossRef] [Google Scholar]
  • Tremey B, Tazarourte K, Ract C, et al (2009) Teaching improves adherence to clinical guidelines in the treatment of oral anticoagulation-related severe bleeding in the emergency department. Intensive Care Med 35:1444–1448. [CrossRef] [PubMed] [Google Scholar]
  • Fang MC, Chang Y, Hylek EM, et al (2004) Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med 141:745–752. [CrossRef] [PubMed] [Google Scholar]
  • Hylek EM, Evans-Molina C, Shea C, et al (2007) Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 115:2689–2696. [CrossRef] [PubMed] [Google Scholar]
  • Desmettre T, Dehours E, Samama CM, et al (2012) Reversal of vitamin K antagonist (VKA) effect in patients with severe bleeding: a french multicenter observational study (Optiplex) assessing the use of prothrombin complex concentrate (PCC) in current clinical practice. Crit Care 16:R185. [CrossRef] [PubMed] [Google Scholar]
  • Tazarourte K, Riou B, Tremey B, et al (2014) Guideline-concordant administration of prothrombin complex concentrate and vitamin K is associated with decreased mortality in patients with severe bleeding under vitamin K antagonist treatment (EPAHK study). Crit Care 18:R81. [CrossRef] [PubMed] [Google Scholar]
  • Miyasaka Y, Barnes ME, Gersh BJ, et al (2006) Secular trends in incidence of atrial fibrillation in Olmstead County, Minnesota, 1980–2000, and implications on the projections for future prevalence. Circulation 114:119–125. [CrossRef] [PubMed] [Google Scholar]
  • Kerebel D, Joly LM, Honnart D, et al (2013) A french multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal Crit Care:17:1–11. [CrossRef] [Google Scholar]
  • Aguilar MI, Hart RG, Kase CS, et al (2007) Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc 82:82–92. [CrossRef] [PubMed] [Google Scholar]
  • Dentali F, Ageno W, Crowther M (2006) Treatment of coumarinassociated coagulopathy: a systematic review and proposed treatment algorithms. J Thromb Haemost 4:1853–1863. [CrossRef] [PubMed] [Google Scholar]
  • Morgenstern LB, Hemphill JC, Anderson C, et al (2010) American Heart Association Stroke Council and Council on Cardiovascular Nursing: Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 41:2108–2129. [CrossRef] [PubMed] [Google Scholar]
  • Steiner T, Kaste M, Forsting M, et al (2006) Recommendations for the management of intracranial haemorrhage part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis 22:294–316. [CrossRef] [PubMed] [Google Scholar]
  • Ansell J, Hirsh J, Hylek E, et al (2008) Pharmacology and management of the vitamin K antagonists: American College of Chest. [Google Scholar]
  • Physicians Evidence-Based Clinical Practice Guidelines. Chest 133:160S–198S. [CrossRef] [PubMed] [Google Scholar]
  • Baglin TP, Keeling DM, Watson HG (2006) Guidelines on oral anticoagulation (warfarin). Br J Haematol 132:277–285. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.